Home
Resources
Product Analysis
Acknowledgements
About
Home
References
Business models
Business models
B2B
Products 61 to 70 of 162
Modify Display Properties
Biotech components
Business models
Country of production
Country of distribution
Intended consumer
Date added
Date last modified
Known funding amount
Funding types
Industry
Market status
Organization
Organization type(s)
Product categories
Production process
Source
Trading symbol
Value chain stage
Sort: Title (A-Z)
Date added (oldest-newest)
Date added (newest-oldest)
Date modified (oldest-newest)
Date modified (newest-oldest)
Title (A-Z)
Title (Z-A)
Organization (A-Z)
Organization (Z-A)
Dragon Silk
by
Kraig Biocraft Laboratories
Biotech components:
Animal
Business models:
B2B
Country of production:
USA
Country of distribution:
USA
+
Vietnam
Intended consumer:
Commercial
+
Government
Date added:
2018/08/30 11:49 (6 years ago)
Date last modified:
2018/08/30 11:49 (6 years ago)
Known funding amount:
5,000,000 USD
Funding types:
Government
+
Shareholder Investment
Industry:
Industrial
Market status:
On the market
Organization type(s):
Public Company
Product categories:
Fiber
Production process:
Closed Production
Source:
Scientist Magazine
Trading symbol:
KBLB
(OTCMKTS)
Value chain stage:
Input
Drought Resistant GM Wheat
by
Bioceres
Biotech components:
Gene Editing
+
Plant
Business models:
B2B
Country of production:
N/A
Country of distribution:
N/A
Intended consumer:
N/A
Date added:
2020/12/18 14:38 (4 years ago)
Date last modified:
2020/12/18 14:38 (4 years ago)
Known funding amount:
N/A
Funding types:
Private Funding
+
University
Industry:
Food & Agriculture
Market status:
Under Development
Organization type(s):
Private Company
Product categories:
Food
Production process:
N/A
Source:
Web search
Trading symbol:
N/A
Value chain stage:
Input
Engineered Insect Strains for Population/Disease Control
by
Oxitec
Biotech components:
Animal
Business models:
B2B
Country of production:
USA
Country of distribution:
Brazil
+
USA
+
India
+
Panama
+
Cayman Islands
Intended consumer:
Commercial
+
Government
Date added:
2018/08/30 11:49 (6 years ago)
Date last modified:
2018/08/30 11:49 (6 years ago)
Known funding amount:
26,132,305 GBP
Funding types:
Private Funding
Industry:
Health
Market status:
Under Development
Organization type(s):
Private Company
Product categories:
Medical Treatment
Production process:
Open Release
Source:
SynBio Database
Trading symbol:
N/A
Value chain stage:
Finished Product
Engineered Microbes for biomining, bioremediation, etc.
by
Universal Bio Mining
Biotech components:
Bacteria
Business models:
B2B
Country of production:
USA
Country of distribution:
USA
Intended consumer:
Commercial
Date added:
2018/08/30 11:49 (6 years ago)
Date last modified:
2018/08/30 11:49 (6 years ago)
Known funding amount:
N/A
Funding types:
N/A
Industry:
Industrial
Market status:
Under Development
Organization type(s):
Private Company
Product categories:
Resource Extraction
Production process:
Open Release
Source:
NASEM Database
Trading symbol:
N/A
Value chain stage:
Input
Epidiolex
by
EPIDIOLEX
Biotech components:
N/A
Business models:
B2B
Country of production:
N/A
Country of distribution:
USA
Intended consumer:
Commercial
+
Consumer
Date added:
2019/04/01 10:02 (6 years ago)
Date last modified:
2019/04/12 09:32 (6 years ago)
Known funding amount:
N/A
Funding types:
N/A
Industry:
Medical
Market status:
On the market
Organization type(s):
Private Company
Product categories:
Medical Treatment
Production process:
Open Release
Source:
Web search
Trading symbol:
N/A
Value chain stage:
Finished Product
Eradicake Alpha-Amylase
by
BASF
+
Verenium
Biotech components:
Enzyme
Business models:
B2B
Country of production:
Switzerland
Country of distribution:
USA
+
Mexico
+
Canada
+
Germany
+
Singapore
+
Brazil
+
China
Intended consumer:
Commercial
Date added:
2018/08/30 11:49 (6 years ago)
Date last modified:
2018/12/26 15:23 (6 years ago)
Known funding amount:
N/A
Funding types:
Shareholder Investment
Industry:
Industrial
Market status:
On the market
Organization type(s):
Public Company
Product categories:
Chemical
Production process:
Closed Production
Source:
SynBio Database
Trading symbol:
BAS
(ETR)
Value chain stage:
Input
EveNootkatone
by
Evolva
Biotech components:
Plant
Business models:
B2B
Country of production:
Switzerland
Country of distribution:
USA
+
Europe
Intended consumer:
Commercial
Date added:
2018/08/30 11:49 (6 years ago)
Date last modified:
2018/08/30 11:49 (6 years ago)
Known funding amount:
86,000,000 CHF
Funding types:
Shareholder Investment
Industry:
Food & Agriculture
Market status:
On the market
Organization type(s):
Public Company
Product categories:
Additive
Production process:
Closed Production
Source:
SynBio Database
Trading symbol:
EVE
(SWX)
Value chain stage:
Input
EverSweet™
by
Evolva
+
Cargill
Biotech components:
Plant
Business models:
B2B
+
B2C
Country of production:
Switzerland
Country of distribution:
USA
+
Europe
Intended consumer:
Consumer
Date added:
2018/08/30 11:49 (6 years ago)
Date last modified:
2018/09/13 15:54 (6 years ago)
Known funding amount:
86,000,000 CHF
Funding types:
Shareholder Investment
Industry:
Food & Agriculture
Market status:
On the market
Organization type(s):
Private Company
Product categories:
Chemical
Production process:
Closed Production
Source:
NASEM Database
Trading symbol:
EVE
(SWX)
Value chain stage:
Input
Farnesene
by
Amyris
Biotech components:
Fungus
Business models:
B2B
Country of production:
USA
Country of distribution:
USA
Intended consumer:
Commercial
Date added:
2018/08/30 11:49 (6 years ago)
Date last modified:
2018/08/30 11:49 (6 years ago)
Known funding amount:
471,900,000 USD
Funding types:
Shareholder Investment
Industry:
Industrial
Market status:
On the market
Organization type(s):
Public Company
Product categories:
Chemical
Production process:
Closed Production
Source:
SynBio Database
Trading symbol:
AMRS
(NASDAQ)
Value chain stage:
Input
Friendly Aedes Mosquito
by
Oxitec
Biotech components:
Animal
Business models:
B2B
Country of production:
UK
Country of distribution:
England
+
USA
Intended consumer:
Government
Date added:
2018/08/30 11:49 (6 years ago)
Date last modified:
2018/08/30 11:49 (6 years ago)
Known funding amount:
36,300,000 USD
Funding types:
Private Funding
Industry:
Health
Market status:
Under Development
Organization type(s):
Private Company
Product categories:
Other
Production process:
Open Release
Source:
SynBio Database
Trading symbol:
N/A
Value chain stage:
Finished Product
1
…
3
4
5
6
7
8
9
10
11
…
17
Login
or
register
to add and edit products
Future
Bioengineered
Products
Home
Resources
Product Analysis
Acknowledgements
About
